Rafael Holdings Inc. (RFL)
RFL trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.49
-1.97% on the day
Market cap
$77.5M
Micro cap
Revenue · 2025
$917K
+44.0% on 2024
Net income · 2025
-$30.5M
-3328.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | RFL on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001713863 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $917K |
| Net income | -$30.5M |
| Operating income | -$29.2M |
| Net margin | -3328.2% |
| Operating margin | -3179.8% |
| Revenue growth | +44.0% |
| Cash | $37.8M |
| Total assets | $99.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 84.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B3 | 2025-05-06 |
| Latest annual report ANNUAL REPORT | 10-K | 2025-10-29 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-06-11 |
| Latest current report CURRENT REPORT | 8-K | 2026-09-30 |
| Latest proxy PROXY STATEMENT | DEF 14A | 2025-11-18 |
Source: SEC EDGAR submissions feed, 406 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PMN | ProMIS Neurosciences Inc. Common Shares (ON) | $8.66 | -8.36% | $77.7M |
| NTHI | NeOnc Technologies Holdings Inc. | $2.60 | -4.95% | $77.2M |
| INCR | Intercure Ltd. | $5.03 | +1.62% | $75.5M |
| ACRV | Acrivon Therapeutics Inc. | $1.75 | -7.89% | $75.0M |
| LFVN | Lifevantage Corporation Common Stock (Delaware) | $5.95 | -0.50% | $74.9M |
| TELO | Telomir Pharmaceuticals Inc. | $1.09 | -0.91% | $80.2M |
| HRTX | Heron Therapeutics Inc. | $0.3906 | -6.01% | $74.2M |
| MNOV | Medicinova Inc | $1.50 | -2.60% | $73.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier